Fort Baker Capital Management’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Fort Baker Capital Management’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-328,698	Closed	-$23.7K	–	79
2024 Q3	$23.7K	Hold	328,698	–	–	﹤0.01%	69
2024 Q2	$20K	Hold	328,698	–	–	﹤0.01%	70
2024 Q1	$98.3K	Hold	328,698	–	–	0.01%	60
2023 Q4	$161K	Sell	328,698 -48,741	-13%	-$13.5K	0.02%	61
2023 Q3	$64.2K	Hold	377,439	–	–	0.01%	68
2023 Q2	$71.7K	Hold	377,439	–	–	0.01%	68
2023 Q1	$49.4K	Buy	+377,439	New	+$72.8K	0.01%	64

Other funds holding RCKTW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Fort Baker Capital Management's RCKTW Position: Q4 2024 in Review

Fort Baker Capital Management sold out of Rocket Pharmaceuticals Warrant (RCKTW) in Q4 2024, closing a stake of 328,698 shares — an estimated $23.7K sold.

Fort Baker Capital Management first reported a position in RCKTW in Q1 2023 and held it in 7 quarters. The position peaked at $161K in Q4 2023. 10 funds tracked by Wall St. Rank hold RCKTW as of Q4 2024.

Fort Baker Capital Management reported no remaining Rocket Pharmaceuticals Warrant position as of Q4 2024 after selling out during the quarter.
Fort Baker Capital Management sold 328,698 Rocket Pharmaceuticals Warrant shares in Q4 2024, an estimated $23.7K.
Fort Baker Capital Management first reported a position in Rocket Pharmaceuticals Warrant in Q1 2023 and held it in 7 quarters.
Fort Baker Capital Management's Rocket Pharmaceuticals Warrant position peaked at $161K in Q4 2023.
10 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q4 2024.

Based on Fort Baker Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.